Magnesium single crystal for biomedical applications and methods of making same

US11730857B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11730857-B2
Application numberUS-202117195997-A
CountryUS
Kind codeB2
Filing dateMar 9, 2021
Priority dateAug 18, 2014
Publication dateAug 22, 2023
Grant dateAug 22, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A biomedical implant ( 16, 18 ) is formed from magnesium (Mg) single crystal ( 10 ). The biomedical implant ( 16, 18 ) may be biodegradable. The biomedical implant ( 16, 18 ) may be post treated to control the mechanical properties and/or corrosion rate thereof said Mg single crystal ( 10 ) without changing the chemical composition thereof. A method of making a Mg single crystal ( 10 ) for biomedical applications includes filling a single crucible ( 12 ) with more than one chamber with polycrystalline Mg, melting at least a portion of said polycrystalline Mg, and forming more than one Mg single crystal ( 10 ) using directional solidification.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of making a Mg single crystal for biomedical applications comprising: filling a single crucible including more than one chamber with polycrystalline Mg; melting at least a portion of said polycrystalline Mg; forming more than one Mg single crystal using directional solidification; and applying an annealing procedure in argon at a temperature maintained below the magnesium melting point for 1 to 50 hrs, thereby eliminating segregation of said Mg alloy during growth of said Mg single crystal. 2. The method of claim 1 , wherein said polycrystalline Mg is a polycrystalline Mg alloy. 3. The method of claim 2 , wherein the magnesium alloy contains rare earth elements. 4. The method according to claims 1 , 2 , or 3 , wherein the controlled crystallization of said Mg crystallization is caused by directional solidification from the Mg melt utilizing at least one method chosen from the Czochralski method, the Bridgman method, and the floating zone method. 5. The method of claim 1 , further comprising linear motion of the crucible of 0.5 mm/hr to 5 mm/hr and a crucible rotation rate of 0-15 rpm. 6. The method of claim 1 , further comprising use of a single crystal of zirconium or magnesium as a seed crystal. 7. The method of claim 1 , wherein the Mg single crystal is grown from a melt exposed to a soaking time of 1-50 hr and a constant soaking temperature of 10-150° C. above the melting point of magnesium. 8. The method of claim 7 , wherein the Mg single crystal is grown from a melt exposed to a soaking time of 30 hr and a constant soaking temperature of 75° C. above the melting point of magnesium. 9. The method of claim 1 , wherein the length to diameter ratio of the single crystals is in a range chosen from 7.5:1, 8.125:1, and 10:1. 10. The method of claim 1 , wherein the annealing temperature is 645° C. and the annealing procedure is applied for 14 hrs. 11. A method of making a Mg single crystal for biomedical applications comprising: filling a split mold crucible locked with a carbon nanotube (CNT) thread or a CNT sheet with polycrystalline Mg; melting at least a portion of said polycrystalline Mg; and forming Mg single crystal using directional solidification.

Assignees

Inventors

Classifications

  • A61L27/047Primary

    Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06 · CPC title

  • Cortical plates {, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates} · CPC title

  • Pins or screws {or threaded wires; nuts therefor (A61B17/72 take precedence)} · CPC title

  • for temporo-mandibular [TM, TMJ] joints (endoprostheses for mandibular reconstruction A61F2/2803) · CPC title

  • Materials at least partially resorbable by the body · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11730857B2 cover?
A biomedical implant ( 16, 18 ) is formed from magnesium (Mg) single crystal ( 10 ). The biomedical implant ( 16, 18 ) may be biodegradable. The biomedical implant ( 16, 18 ) may be post treated to control the mechanical properties and/or corrosion rate thereof said Mg single crystal ( 10 ) without changing the chemical composition thereof. A method of making a Mg single crystal ( 10 ) for biom…
Who is the assignee on this patent?
Univ Cincinnati
What technology area does this patent fall under?
Primary CPC classification A61L27/047. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).